rap chart, page-2127

RAP valuation is from its disruptive concept and outlook IMO. SP can be anywhere between 30-50c related to how quickly FDA and first deal to land. There’s little doubt about other commerciality follow suit.

Cannot really comment on other particular one but lots of digital health stocks are slow with revenue expansion while fixed cost incurred is huge. In this respect people are more optimistic imagining RAP being $1 with the start of some decent deal